Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Newly identified molecules can help develop COVID-19 therapeutics

Newly identified molecules can help develop COVID-19 therapeutics

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

Discovery provides a potential target for infectious diseases immunotherapy

Discovery provides a potential target for infectious diseases immunotherapy

HCV-positive organs can be safely used for transplantation, study shows

HCV-positive organs can be safely used for transplantation, study shows

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

Scientists develop new test to help identify people at risk for developing liver cancer

Scientists develop new test to help identify people at risk for developing liver cancer

Females mount stronger T-cell response to SARS-CoV-2

Females mount stronger T-cell response to SARS-CoV-2

Research team provides new insights on the communication between liver and brain

Research team provides new insights on the communication between liver and brain

Kidney enzyme renalase a potential therapy for severe COVID-19

Kidney enzyme renalase a potential therapy for severe COVID-19

Study shows women are less susceptible to cirrhosis-related deaths

Study shows women are less susceptible to cirrhosis-related deaths

New detection platform may help speed up viral diagnosis

New detection platform may help speed up viral diagnosis

Study shows Sofosbuvir alleviates COVID-19-related neurological symptoms

Study shows Sofosbuvir alleviates COVID-19-related neurological symptoms

New detection platform for rapid diagnosis of infectious diseases

New detection platform for rapid diagnosis of infectious diseases

A key player in hepatitis A virus infection discovered

A key player in hepatitis A virus infection discovered

Study shows selenium-containing compounds inhibit SARS-CoV-2 replication and assembly

Study shows selenium-containing compounds inhibit SARS-CoV-2 replication and assembly

Lifesaving innovation for COVID-19 will increase the already existing racial inequalities

Lifesaving innovation for COVID-19 will increase the already existing racial inequalities

Does COVID-19 infect peripheral blood cells?

Does COVID-19 infect peripheral blood cells?

Three FDA-approved drugs can block the replication of COVID-19 virus

Three FDA-approved drugs can block the replication of COVID-19 virus

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers